Cargando…

Identification of candidate repurposable drugs to combat COVID-19 using a signature-based approach

The COVID-19 pandemic caused by the novel SARS-CoV-2 is more contagious than other coronaviruses and has higher rates of mortality than influenza. Identification of effective therapeutics is a crucial tool to treat those infected with SARS-CoV-2 and limit the spread of this novel disease globally. W...

Descripción completa

Detalles Bibliográficos
Autores principales:	O’Donovan, Sinead M., Imami, Ali, Eby, Hunter, Henkel, Nicholas D., Creeden, Justin Fortune, Asah, Sophie, Zhang, Xiaolu, Wu, Xiaojun, Alnafisah, Rawan, Taylor, R. Travis, Reigle, James, Thorman, Alexander, Shamsaei, Behrouz, Meller, Jarek, McCullumsmith, Robert E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904823/ https://www.ncbi.nlm.nih.gov/pubmed/33627767 http://dx.doi.org/10.1038/s41598-021-84044-9

Ejemplares similares

Identification of new drug treatments to combat COVID19: A signature-based approach using iLINCS
por: O’Donovan, Sinead M, et al.
Publicado: (2020)

Fluoxetine as an anti-inflammatory therapy in SARS-CoV-2 infection
por: Creeden, Justin Fortune, et al.
Publicado: (2021)

Strategies to identify candidate repurposable drugs: COVID-19 treatment as a case example
por: Imami, Ali S., et al.
Publicado: (2021)

Altered purinergic receptor expression in the frontal cortex in schizophrenia
por: Alnafisah, Rawan, et al.
Publicado: (2022)

Gene Enrichment Analysis of Astrocyte Subtypes in Psychiatric Disorders and Psychotropic Medication Datasets
por: Zhang, Xiaolu, et al.
Publicado: (2022)

Subcellular partitioning of protein kinase activity revealed by functional kinome profiling
por: Wegman-Points, Lauren, et al.
Publicado: (2022)

Adenosine, Schizophrenia and Cancer: Does the Purinergic System Offer a Pathway to Treatment?
por: Hamoud, Abdul-Rizaq, et al.
Publicado: (2022)

32.2 ABNORMALITIES OF SYNAPTIC PROTEOMES IN SCHIZOPHRENIA
por: Funk, Adam, et al.
Publicado: (2018)

SSRIs: Applications in inflammatory lung disease and implications for COVID‐19
por: Meikle, Claire Kyung Sun, et al.
Publicado: (2021)

S183. ABNORMALITIES IN SERINE/THREONINE SIGNALING NETWORKS IN SEVERE NEUROPSYCHIATRIC ILLNESS: DEVELOPMENT OF A PIPELINE TO EXPLORE ABNORMALITIES OF KINASE ACTIVITY AND IDENTIFY NOVEL TREATMENT STRATEGIES FOR SCHIZOPHRENIA
por: McCullumsmith, Robert, et al.
Publicado: (2020)

The role of glutamate transporters in the pathophysiology of neuropsychiatric disorders
por: O’Donovan, Sinead M., et al.
Publicado: (2017)

Transcriptional profile of pyramidal neurons in chronic schizophrenia reveals lamina-specific dysfunction of neuronal immunity
por: Wu, Xiaojun, et al.
Publicado: (2021)

Using protein turnover to expand the applications of transcriptomics
por: Smail, Marissa A., et al.
Publicado: (2021)

F201. KINASE NETWORK DYSREGULATION IN SCHIZOPHRENIA: IMPLICATIONS FOR NEW TREATMENT STRATEGIES
por: Bentea, Eduard, et al.
Publicado: (2018)

Emerging Kinase Therapeutic Targets in Pancreatic Ductal Adenocarcinoma and Pancreatic Cancer Desmoplasia
por: Creeden, Justin F., et al.
Publicado: (2020)

12.2 METABOLIC CONSEQUENCES OF DEVELOPMENTAL NMDA RECEPTOR HYPOFUNCTION
por: Funk, Adam, et al.
Publicado: (2018)

Similarities and dissimilarities between psychiatric cluster disorders
por: Smail, Marissa A., et al.
Publicado: (2021)

Neuron-specific deficits of bioenergetic processes in the dorsolateral prefrontal cortex in schizophrenia
por: Sullivan, Courtney R., et al.
Publicado: (2018)

Kinome Array Profiling of Patient-Derived Pancreatic Ductal Adenocarcinoma Identifies Differentially Active Protein Tyrosine Kinases
por: Creeden, Justin F., et al.
Publicado: (2020)

Cellular, molecular, and therapeutic characterization of pilocarpine-induced temporal lobe epilepsy
por: Henkel, Nicholas D., et al.
Publicado: (2021)

12.1 CELL-SUBTYPE SPECIFIC BIOENERGETIC DEFECTS IN SCHIZOPHRENIA
por: Sullivan, Courtney, et al.
Publicado: (2018)

Glutamate transporter splice variant expression in an enriched pyramidal cell population in schizophrenia
por: O'Donovan, S M, et al.
Publicado: (2015)

Abnormalities of signal transduction networks in chronic schizophrenia
por: McGuire, Jennifer L., et al.
Publicado: (2017)

Measurement of lactate levels in postmortem brain, iPSCs, and animal models of schizophrenia
por: Sullivan, Courtney R., et al.
Publicado: (2019)

Activation of acid‐sensing ion channels by carbon dioxide regulates amygdala synaptic protein degradation in memory reconsolidation
por: Lin, Boren, et al.
Publicado: (2021)

Repurposing Immunomodulatory Drugs to Combat Tuberculosis
por: Fatima, Samreen, et al.
Publicado: (2021)

Molecular and Metabolic Subtypes in Sporadic and Inherited Clear Cell Renal Cell Carcinoma
por: Czyzyk-Krzeska, Maria F., et al.
Publicado: (2021)

Combating devastating COVID-19 by drug repurposing
por: Pawar, Ashish Yashwantrao
Publicado: (2020)

Drug Repurposing Approaches to Combating Viral Infections
por: Trivedi, Jay, et al.
Publicado: (2020)

Combating Intracellular Pathogens with Repurposed Host-Targeted Drugs
por: Schor, Stanford, et al.
Publicado: (2018)

Repurposing the anthelmintic drug niclosamide to combat Helicobacter pylori
por: Tharmalingam, Nagendran, et al.
Publicado: (2018)

Combating Ebola with Repurposed Therapeutics Using the CANDO Platform
por: Chopra, Gaurav, et al.
Publicado: (2016)

Disclosing the potential impact of placebo controls in antidepressant trials
por: Chen, Stephanie C., et al.
Publicado: (2015)

Repurposing Clinical Molecule Ebselen to Combat Drug Resistant Pathogens
por: Thangamani, Shankar, et al.
Publicado: (2015)

Combating COVID-19: The role of drug repurposing and medicinal plants
por: Khan, Shah A., et al.
Publicado: (2021)

Editorial: Repurposed Drugs as Immune-Modulators to Combat Infectious Diseases
por: Mishra, Bibhuti B., et al.
Publicado: (2022)

Repurposing Salicylanilide Anthelmintic Drugs to Combat Drug Resistant Staphylococcus aureus
por: Rajamuthiah, Rajmohan, et al.
Publicado: (2015)

Clinical features and mechanistic insights into drug repurposing for combating COVID-19
por: Asrani, Purva, et al.
Publicado: (2022)

Ampa Receptor Subunit Expression in the Endoplasmic Reticulum in Frontal Cortex of Elderly Patients with Schizophrenia
por: Hammond, John C., et al.
Publicado: (2012)

Hepatic kinome atlas: An in‐depth identification of kinase pathways in liver fibrosis of humans and rodents
por: Creeden, Justin F., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ektg671l30m1befpi9ofucsurl